Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,567.20
(
1.22%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
100.53
(
3.86%
)
Bitcoin
70,478.00
(
-0.60%
)
News Focus
News Focus
Post# of 257273
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 235206

Monday, 11/23/2020 8:41:17 AM

Monday, November 23, 2020 8:41:17 AM

Post# of 257273
MRK submits BLA/MAA for V114 pneumococcal vaccine in adults:

https://finance.yahoo.com/news/merck-submits-applications-licensure-v114-114700204.html

Many investors and analysts think PFE’s Prevnar 20, which covers five more serotypes than V114, will make V114 commercially irrelevant (#msg-154634395).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today